Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
A. M. Atalis, M. C. Keenum, B. Pandey, A. Beach, P. Pradhan, C. E. Vantucci, R. Jain, J. Hosten, C. Smith, L. L. Kramer, A. C. Jimenez, M. A. Armenta-Ochoa, D. A. Frey, K. Roy
This study shows that nanoparticle-delivered TLR4 and RIG-I agonists enhance immune responses to a SARS-CoV-2 subunit vaccine in mice, with route-specific effects on T and B cell responses.
bioRxiv · Jan 31, 2022Immunology